Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides

Journal of Immunology

Volumn 162, Issue 10, 1999, Pages 6284-6293

  Sur, Sanjiv ^a   Wild, James S ^a   Choudhury, Barun K ^a   Sur, Nilanjana ^a   Alam, Rafeul ^a   Klinman, Dennis M ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; OLIGODEOXYNUCLEOTIDE; RAGWEED ANTIGEN;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CPG ISLAND; DRUG EFFECT; EOSINOPHIL; FEMALE; HELPER CELL; IMMUNOLOGICAL MEMORY; INTRATRACHEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION;

ALLERGENS; ANIMALS; ANTI-ALLERGIC AGENTS; ASTHMA; CHEMOTAXIS, LEUKOCYTE; CYTIDINE; DINUCLEOSIDE PHOSPHATES; DISEASE MODELS, ANIMAL; FEMALE; GUANOSINE; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; NEBULIZERS AND VAPORIZERS; OLIGODEOXYRIBONUCLEOTIDES; PLANT PROTEINS; POLLEN; PULMONARY EOSINOPHILIA; TH1 CELLS; TH2 CELLS; TIME FACTORS; TRACHEA;

EID: 0033563211     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Sears, M. R. 1991. Worldwide trends in asthma mortality. Bull. Int. Union Tuberc. 66:79.
2. MMWR. 1979. Asthma mortality and hospitalizations among children and young adults: United States. MMWR 45:350.
3. Martin, L. B., H. Kita, K. M. Leiferman, and G. J. Gleich. 1996. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int. Arch. Allergy Immunol. 109:207.
4. Sur, S., C. Adolphson, and G. J. Gleich. 1993. Eosinophils: biochemical and cellular aspects. In Allergy: Principles and Practice. Vol. 1. E. Middleton, Jr., C. E. Reed, E. F. Ellis, N. F. Adkinson, J. W. Yunginger, and W. W. Busse, eds. Mosby, St. Louis, p. 169.
5. Gleich, G. J., D. B. Jacoby, and A. D. Fryer. 1995. Eosinophil-associated inflammation in bronchial asthma: a connection to the nervous system. Int. Arch. Allergy Immunol. 107:205.
6. Gundel, R. H., L. G. Letts, and G. J. Gleich. 1991. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J. Clin. Invest. 87:1470.
7. White, S. R., S. Ohno, N. M. Munoz, G. J. Gleich, C. Abrahams, J. Solway, and A. R. Leff. 1990. Epithelium-dependent contraction of airway smooth muscle caused by eosinophil MBP. Am. J. Physiol. 259:1294.
8. Gleich, G. J., and G. L. Jacob. 1975. Immunoglobulin E antibodies to pollen allergens account for high percentages of total immunoglobulin E protein. Science 190:1106.
9. Solley, G. O., G. J. Gleich, R. E. Jordon, and A. L. Schroeter. 1976. The late phase of the immediate wheal and flare skin reaction: Its dependence upon IgE antibodies. J. Clin. Invest. 58:408.
10. Coyle, A. J., K. Wagner, C. Bertrand, S. Tsuyuki, J. Bews, and C. Heusser. 1996. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic ami-IgE antibody. J. Exp. Med. 183:1303.
11. Ohnishi, T., S. Sur, D. S. Collins, J. E. Fish, G. J. Gleich, and S. P. Peters. 1993. Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen lung challenge. J. Allergy Clin. Immunol. 92:607.
12. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am. Rev. Respir. Dis. 146:374.
13. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298.
14. Coyle, A. J., G. Le Gros, C. Bertrand, S. Tsuyuki, C. H. Heusser, M. Kopf, and G. P. Anderson. 1995. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am. J. Respir. Cell Mol. Biol. 13:54.
15. Brusselle, G., J. Kips, G. Joos, H, Bluethmann, and R. Pauwels. 1995. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am. J. Respir. Cell Mol. Biol. 12:254.
16. Iwamoto, I., H. Nakajima, H. Endo, and S. Yoshida. 1993. Interferon γ regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J. Exp. Med. 177:573.
17. Sur, S., J. Lam, P. Bouchard, A. Sigounas, D. Holbert, and W. J. Metzger. 1996. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J. Immunol. 157:4173.
18. Krieg, A. M., A. K. Yi, S. Matson, T.J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA Bigger direct B-cell activation. Nature 374:546.
19. Klinman, D. M., A. K. Yi, S. L. Beaucage, J. Conover, and A. M. Krieg. 1996. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and Interferon gamma. Proc. Natl. Acad. Sci. USA 93:2879.
20. Kline, J. N., T. J. Waldschmidt, T. R. Businga, J. E. Lemish, J. V. Weinstock, P. S. Thorne, and A.M. Krieg. 1998. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160:2555.
21. Broide, D., J. Schwarze, H. Tighe, T. Gifford, M. D. Nguyen, S. Malek, J. Van Uden, E. Martin-Orozco, E. W. Gelfand, and E. Raz. 1998. Immuno-stimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 161:7054.
22. Hunt, L. W., G. J. Gleich, T. Ohnishi, D. A. Weiler, E. S. Mansfield, H. Kita, and S. Sur. 1994. Endotoxin contamination causes neutrophilia following pulmonary allergen challenge. Am. J. Respir. Crit. Care Med. 149:1471.
23. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156:766.
24. Ashcroft, T., J. M. Simpson, and V. Timbrell. 1988. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41:467.
25. Krieg, A. M., L. Love-Homan, and J. T. Harry. 1998 CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161:2428.
26. 1 in mice. J. Clin. Invest. 97:1398.
27. Alam, R., J. York, M. Boyars, S. Stafford, J. A. Grant, J. Lee, P. Forsythe, T. Sim, and N. Ida. 1996. Increased MCP-1, RANTES, and MIP-1a in bronchoalveolar lavage fluid of allergic asthmatic patients. Am. J. Respir. Crit. Care Med. 153: 1398.
28. Sur, S., H. Kita, G. J. Gleich, T. C. Chenier, and L. W. Hunt. 1996. Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty-four hours after allergen challenge. J. Allergy Clin. Immunol. 97:1272.
29. Teran, L. M., N. Noso, M. Carroll, D. E. Davies, S. Holgate, and J. M Schroder. 1996. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J. Immunol. 157: 1806.
30. Siveke, J. T., and A. Hamann. 1998. Cutting edge: T helper 1 and T helper 2 cells respond differentially to chemokines. J. Immunol. 160:550.
31. Schrum, S., P. Probst, B. Fleischer, and P. F. Zipfel. 1996. Synthesis of the CC-chemokines MIP-1-α, MIP-1-0, and RANTES is associated with a type 1 immune response. J. Immunot. 157:3598.
32. Gavett, S. H., D. J. O'Heara, X. Li, S. K. Huang, F. D. Finkelman, and M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med, 182:1527.
33. Schwarze, J., E. Hamelmann, G. Cieslewicz, A. Tomkinson, A. Joetham, K. Bradley, and E. W. Gelfand. 1998. Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice. J. Allergy Clin. Immunol. 102:86.
34. Kips, J.C., G. J. Brusselle, G. F. Joos, R. A. Peleman, J. H. Tavernier, R. R. Devos, and R. A. Pauwels. 1996. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 153:535.
35. Iwamoto, I., K. Kumano, M. Kasai, K. Kurasawa, and A. Nakao. 1996. Interleukin-12 prevents antigen-induced eosinophil recruitment into mouse airways. Am. J. Respir. Crit. Care Med. 154:1257.
36. Sur, S., S. Siddique, R. Alam, W. J. Mileski, P. Bouchard, G. Sarkar, A. Sigounas, and J. S. Wild. 1999. Strategies for the development of vaccines for asthma. J. Allergy Clin. Immunol. 103:S107 (Abstr.).
37. Afonso, L. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235.
38. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Caspar, F. A. Lewis, and A. Sher. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594.
39. Wynn, T. A., A. Reynolds, S. James, A. W. Cheever, P. Caspar, S. Hieny, D. Jankovic, M. Strand, and A. Sher. 1996. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J. Immunol. 157:4068.
40. Nakajima, H., I. Iwamoto, and S. Yoshida. 1993. Aerosolized recombinant interferon-γ prevents antigen-induced eosinophil recruitment in mouse trachea. Am. Rev. Respir. Dis. 148:1102.
41. Boguniewicz, M., R. J. Martin, D. Martin, U. Gibson, A. Celniker, M. Williams, and D. Y. Leung. 1995. The effects of nebulized recombinant interferon-γ in asthmatic airways. J. Allergy Clin. Immunol. 95:133.
42. Scholz, D., K. Brandt-Hofflin, and H. L. Hahn. 1990. [Effect of recombinant gamma interferon on allergic skin reaction and bronchoconstriction] [in German]. Pneumologie 44(Suppl. 1):431.
43. Li, J. T., I. W. Vunginger, C. E. Reed, H. S. Jaffe, D. R. Nelson, and G. J. Gleich. 1990. Lack of suppression of IgE production by recombinant interferon γ: a controlled trial in patients with allergic rhinitis. J. Allergy Clin. Immunol. 85:934.
44. Leonard, J. P., M. L. Sherroan, G. L. Fisher, L. J. Buchanan, G. Larsen, M. B. Atkins, J. A. Sosman, J. P. Dutcher, N. J. Vogelzang, and J. L. Ryan. 1997. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-γ production. Blood 90:2541.
45. Erb, K. J., J. W. Holloway, A. Sobeck, H. Moll, and G. Legros. 1998. Infection of mice with Mycobacterium bovis-bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia. J. Exp. Med. 187:561.
46. Schwartz, D. A., T. J. Quinn, P. S. Thorne, S. Sayeed, A. K. Yi, and A. M. Krieg. 1997. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J. Clin. Invest. 100:68.
47. Cardon, L. R., C. Burge, D. A. Clayton, and S. Karlin. 1994. Pervasive CpG suppression in animal mitochondrial genomes. Proc. Natl. Acad. Sci. USA 91: 3799.
48. Shirakawa, T., T. Enomoto, S. Shimazu, and J. M. Hopkin. 1997. The inverse association between tuberculin responses and atopic disorder [see comments]. Science 275:77.
49. Boulet, L. P., K. R. Chapman, J. Cote, S. Kalra, R. Bhagat, V. A. Swystun, M. Laviolette, L. D. Cleland, F. Deschesnes, J. Q. Su, A. DeVault, R. B. Pick, Jr., and D. W. Cockcroft. 1997. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response [see comments]. Am. J. Respir. Crit. Care Med. 155:1835.
50. Fahy, J. V., H. E. Fleming, H. H. Wong, J. T. Liu, J. Q. Su, J. Reimann, R. B. Fick, Jr., and H. A. Boushey. 1997. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects [see comments]. Am. J. Respir. Crit. Care Med. 155:1828.
51. Strannegard, I. L., L. O. Larsson, G. Wennergren, and O. Strannegard. 1998. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 53:249.